Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $24,982 - $28,466
-441 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$62.1 - $78.08 $27,386 - $34,433
441 New
441 $28,000
Q2 2020

Aug 14, 2020

SELL
$72.34 - $84.0 $37,255 - $43,260
-515 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$62.63 - $80.22 $10,772 - $13,797
172 Added 50.15%
515 $40.1 Million
Q4 2019

Feb 14, 2020

BUY
$61.62 - $67.78 $5,915 - $6,506
96 Added 38.87%
343 $22.1 Million
Q3 2019

Nov 13, 2019

BUY
$62.51 - $69.0 $15,439 - $17,043
247 New
247 $15,000
Q2 2019

Aug 16, 2019

SELL
$61.87 - $69.38 $54,631 - $61,262
-883 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$62.53 - $70.05 $55,213 - $61,854
883 New
883 $0

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Advisory Alpha, LLC Portfolio

Follow Advisory Alpha, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Alpha, LLC with notifications on news.